Campbell & CO Investment Adviser LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$749,618
+251.9%
46,416
+1413.9%
0.09%
+57.9%
Q2 2022$213,000
-60.6%
3,066
-57.4%
0.06%
-69.2%
Q4 2021$541,000
+87.8%
7,200
+453.8%
0.18%
+55.5%
Q2 2021$288,000
+20.0%
1,300
-54.4%
0.12%
+60.8%
Q4 2019$240,000
-0.4%
2,848
-25.2%
0.07%
-32.1%
Q2 2019$241,0000.0%3,805
-50.6%
0.11%
-41.1%
Q2 2018$241,0007,7000.18%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders